
Atomwise
Atomwise uses a machine learning platform to discover novel, drug-like molecules.
$120M Series B+ ·
Source: startupintros.com
Latest round on record: Series B+, March 2025, amount undisclosed.
Total raised: $171M across 3 sourced rounds
All 4 rounds ↓Signals
About Atomwise
Its programs deliver potential in immune and inflammatory diseases. Atomwise offers a machine learning-based drug discovery service.
Atomwise | 4186 days on the record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | startupintros.com | |
| Series B+ | $120M | — | startupintros.com | |
| Series A | $45M | — | startupintros.com | |
| Seed | $6M | — | startupintros.com |
Timeline
- Website created
Founders and team
AH
Abraham Heifets Co-Founder and CEOLinkedIn · source: foundertrace.com
Companies like Atomwise
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
BBiossil$153M Seed · Sep 2026
EExeliom BiosciencesSeries A · Oct 2025MMirador Therapeutics$250M Series B+ · Jan 2026
JJnana Therapeutics$107M Series B+ · Nov 2022
IImmunai$215M Series B+ · Oct 2021
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/atomwise (get a free API key).